Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1

被引:59
|
作者
Misumi, Shogo [1 ]
Inoue, Mutsumi
Dochi, Takeo
Kishimoto, Naoki
Hasegawa, Naomi
Takamune, Nobutoki
Shoji, Shozo [1 ,2 ]
机构
[1] Kumamoto Univ, Dept Pharmaceut Biochem, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan
[2] Kumamoto Hlth Sci Univ, Kumamoto 8615598, Japan
基金
日本学术振兴会;
关键词
2-DIMENSIONAL GEL-ELECTROPHORESIS; CYCLE-DEPENDENT PHOSPHORYLATION; FLIGHT MASS-SPECTROMETRY; HIV-1 CAPSID PROTEIN; INTRACELLULAR TRAFFICKING; IN-VITRO; CELL; INFECTION; DOMAIN; GENE;
D O I
10.1074/jbc.M110.114256
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The process by which the human immunodeficiency virus type 1 (HIV-1) conical core dissociates is called uncoating, but not much is known about this process. Here, we show that the uncoating process requires the interaction of the capsid (CA) protein with the peptidyl-prolyl isomerase Pin1 that specifically recognizes the phosphorylated serine/threonine residue followed by proline. We found that the HIV-1 core is composed of some isoforms of the CA protein with different isoelectric points, and one isoform is preferentially phosphorylated in the Ser(16)-Pro(17) motif. The mutant virus S16A/P17A shows a severely attenuated HIV-1 replication and an impaired reverse transcription. The S16A/P17A change increased the amount of particulate CA cores in the cytosol of target cells and correlated with the restriction of HIV-1 infection. Glutathione S-transferase pulldown assays demonstrated a direct interaction between Pin1 and the HIV-1 core via the Ser(16)-Pro(17) motif. Suppression of Pin1 expression by RNA interference in a target cell results in an attenuated HIV-1 replication and increases the amount of particulate CA cores in the cytosol of target cells. Furthermore, heat-inactivated, inhibitor-treated, or W34A/K63A Pin1 causes an attenuated in vitro uncoating of the HIV-1 core. The Pin1-dependent uncoating is inhibited by antisera raised against a CA peptide phosphorylated at Ser(16) or treatment of the HIV-1 core with alkaline phosphatase. These findings provide insights into this obscure uncoating process in the HIV-1 life cycle and a new cellular target for HIV-1 drug development.
引用
收藏
页码:25185 / 25195
页数:11
相关论文
共 50 条
  • [41] The Prolyl Isomerase Pin1 Enhances HER-2 Expression and Cellular Transformation via Its Interaction with Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase 1
    Khanal, Prem
    Namgoong, Gwang Mo
    Kang, Bong Seok
    Woo, Eun-Rhan
    Choi, Hong Seok
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (03) : 606 - 616
  • [42] Novel factors interfering with human immunodeficiency virus-type 1 replication in vivo and in vitro
    Vicenzi, E.
    Poli, G.
    TISSUE ANTIGENS, 2013, 81 (02): : 61 - 71
  • [43] Evidence of ongoing replication in a human immunodeficiency virus type 1 persistently infected cell line
    Olivares, Isabel
    Sanchez-Jimenez, Carmen
    Reis Vieira, Catarina
    Toledano, Victor
    Gutierrez-Rivas, Monica
    Lopez-Galindez, Cecilio
    JOURNAL OF GENERAL VIROLOGY, 2013, 94 : 944 - 954
  • [44] Primary human immunodeficiency virus type 1 infection in a patient with acute rhabdomyolysis
    McDonagh, CA
    Holman, RP
    SOUTHERN MEDICAL JOURNAL, 2003, 96 (10) : 1027 - 1030
  • [45] Astroglial reaction pattern in human immunodeficiency virus type 1 infected brains
    Itoh, K
    Mehraein, P
    Weis, S
    NEUROPATHOLOGY, 1996, 16 (04) : 225 - 230
  • [46] Human immunodeficiency Virus Type 1 Evolution in Non-B Subtypes
    Dimitrios, Coutsinos
    Mark, Waiberg A.
    NEW APPROACHES IN CORONARY ARTERY DISEASE: PROCEEDINGS OF THE 8TH INTERNATIONAL CONGRESS ON CORONARY ARTERY DISEASE, 2009, : 63 - 68
  • [47] Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1
    Dziuba, Natallia
    Ferguson, Monique R.
    O'Brien, William A.
    Sanchez, Anthony
    Prussia, Andrew J.
    McDonald, Natalie J.
    Friedrich, Brian M.
    Li, Guangyu
    Shaw, Michael W.
    Sheng, Jinsong
    Hodge, Thomas W.
    Rubin, Donald H.
    Murray, James L.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (10) : 1329 - 1339
  • [48] Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment
    Smith, R
    Malee, K
    Charurat, M
    Magder, L
    Mellins, C
    MacMillan, C
    Hittleman, J
    Lasky, T
    Llorente, A
    Moye, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (09) : 862 - 871
  • [49] Human immunodeficiency virus type 1 infection, clinical trials and ethics in paediatrics
    deMartino, M
    Galli, L
    Amato, AG
    Vierucci, A
    ACTA PAEDIATRICA, 1997, 86 : 78 - 85
  • [50] Predicting the Impact of Blocking Human Immunodeficiency Virus Type 1 Nef In Vivo
    Wick, W. David
    Gilbert, Peter B.
    Yang, Otto O.
    JOURNAL OF VIROLOGY, 2009, 83 (05) : 2349 - 2356